Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2020 Aug 14:2020.08.11.20171967. [Version 1] doi: 10.1101/2020.08.11.20171967

Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype

William Bain, Hernan F Penaloza, Mark S Ladinsky, Rick van der Geest, Mara Sullivan, Mark Ross, Georgios D Kitsios, Barbara Methe, Bryan J McVerry, Alison Morris, Alan M Watson, Simon C Watkins, Claudette M St Croix, Donna B Stolz, Pamela J Bjorkman, Janet S Lee
PMCID: PMC7430612  PMID: 32817968

Abstract

SARS-CoV-2 pneumonia may induce an aberrant immune response with brisk recruitment of myeloid cells into the lower respiratory tract, which may contribute to morbidity and mortality. We describe endotracheal aspirate samples from seven patients with SARS-CoV-2 pneumonia requiring mechanical ventilation. We note SARS-CoV-2 virions within lower respiratory tract myeloid cells shown by electron tomography, immunofluorescence confocal imaging, and immuno-electron microscopy. Endotracheal aspirates are primarily composed of mononuclear and polymorphonuclear leukocytes. These myeloid cells that harbor virus are frequently positive for CD14 and/or CD16 and most display an inflammatory phenotype marked by expression of IL-6 and tissue factor mRNA transcript and protein expression.

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES